Form of Stock-settled Stock Appreciation Rights Agreement



 Exhibit 10.46 
 ACCO BRANDS CORPORATION 
 AMENDED AND RESTATED 2005 LONG-TERM INCENTIVE PLAN 
 STOCK-SETTLED STOCK APPRECIATION RIGHTS AGREEMENT 
 THIS AGREEMENT is made and entered into and effective                     , 20    
(the “Grant Date”) by and between ACCO Brands Corporation, a Delaware corporation (collectively with all Subsidiaries, the “Company”) and
                     (“Grantee”). 
 WHEREAS, Grantee is a Key Employee of the Company and in compensation for Grantee’s services, the Board deems it advisable to award to Grantee Stock-Settled Stock Appreciation Rights representing a right to
receive shares of the Company’s Common Stock, pursuant to the ACCO Brands Corporation Amended and Restated 2005 Long-Term Incentive Plan (“Plan”), as set forth herein. 
 NOW THEREFORE, subject to the terms and conditions set forth herein: 
 1.        Plan Governs; Capitalized Terms. This Agreement is made pursuant to the Plan, and the terms of the Plan are incorporated into this Agreement, except as
otherwise specifically stated herein. Capitalized terms used in this Agreement that are not defined in this Agreement shall have the meanings as used or defined in the Plan. References in this Agreement to any specific Plan provision shall not be
construed as limiting the applicability of any other Plan provision. 
 2.        Grant of
SSAR. The Company hereby grants to Grantee Stock-Settled Stock Appreciation Rights (“SSARs”) relating to              shares of Common Stock, with an exercise
price of $        .     per share (the “Exercise Price”), which price is the Fair Market Value of one share of Common Stock on the Grant Date. 
 THIS AWARD IS CONDITIONED ON GRANTEE SIGNING THIS AGREEMENT AND RETURNING IT TO THE COMPANY BY
                    , 20    , AND IS SUBJECT TO ALL TERMS, CONDITIONS AND PROVISIONS OF THE PLAN AND THIS
AGREEMENT, WHICH GRANTEE ACCEPTS UPON SIGNING AND DELIVERING THIS AGREEMENT TO THE COMPANY. 
 3.        VESTING, EXERCISE, EXPIRATION AND TERMINATION OF THE SSARS. 
 (a)        The SSARs shall have a term expiring on the seventh anniversary of the Grant Date (“Term”), or earlier as otherwise provided in this Section 3. 
  

 1 








 (b)        Subject to Section 3(c), 3(d),
3(e), 3(f), 3(g), and 3(h), hereof, the SSARs shall become vested and exercisable pursuant to the following schedule: 
  

			
	 Vesting Date
	  	 Portion of SSARs that is Vested and Exercisable

	 First Anniversary of
 the Grant Date
	  	A Total of One-Third of the SSARs
		
	 Second Anniversary of
 the Grant Date
	  	A Total of Two-Thirds of the SSARs
		
	 Third Anniversary of
 the Grant Date
	  	A Total of Three-Thirds of the SSARs

 (c)        Death. Any unvested portion of the SSARs
shall fully vest and become exercisable upon termination of Grantee’s employment due to Grantee’s death while employed by the Company. 
 (d)        Disability. Any unvested portion of the SSARs shall fully vest and become exercisable upon termination of Grantee’s employment due to Grantee’s Disability, provided that
Grantee shall have been in the continuous employ of the Company for at least one year from the Grant Date through the date of such termination. 
 (e)        Other Terminations. Unless the Committee shall otherwise determine, upon a termination of Grantee’s employment for any reason, other than due to Grantee’s death, and other
than due to a termination of Grantee’s employment on or after the first anniversary of the Grant Date due to Disability, prior to the date on which the SSARs shall have fully vested, the unvested portion of the SSARs shall be immediately
forfeited and not exercisable. Any forfeited portion of the SSARs shall be automatically cancelled and shall terminate. 
 (f)        Change in Control. Immediately upon the occurrence of a Change in Control of the Company, or the involuntary termination of Grantee’s employment by the Company within 90 days
prior to a Change in Control but at the direction of any third party participating in or causing the Change in Control or otherwise in contemplation of the Change in Control, the unvested portion of the SSARs shall immediately fully vest and shall
be exercisable, without regard for any termination of Grantee’s employment within one year following the Grant Date. 
 (g)        Contrary Other Agreement. The provisions of Section 3(e) and 3(f) to the contrary notwithstanding, if Grantee and the Company have entered into an employment or
other agreement which provides for vesting treatment of Grantee’s SSARs upon a termination of Grantee’s employment with the Company (and all Affiliates) that is inconsistent with the provisions of Section 3(e) or 3(f),
the more favorable to Grantee of the terms of (i) such employment or other agreement and (ii) Section 3(e) or 3(f), as the case may be, shall control. 
  

 2 








 (h)        Exercise Period for Vested Portion of the
SSARs. Except in the case of a termination of Grantee’s employment due to death or Disability or Retirement, upon a termination of Grantee’s employment with the Company for any reason, the vested portion of Grantee’s SSARs shall
be exercisable for a period of three months following the date of such termination. In the case of Grantee’s death, or termination of Grantee’s employment due to Disability or Retirement, the SSARs shall be exercisable for five years
following such death or termination of employment. The foregoing provisions of this Section 3(h) to the contrary notwithstanding, the SSARs shall expire and cease to be exercisable on the last day of the term of the SSAR set forth in
Section 3(a) hereof, except that, in the case of the death of Grantee during Grantee’s employment by the Company, to the extent the SSARs otherwise would expire, such expiration date shall be deemed extended for one year following
Grantee’s date of death. 
 4.        Exercise; Issuance of Shares. Grantee may exercise
the vested SSARs, or any vested portion thereof, by notice of exercise to the Company in a manner (which may include election means) approved by the Committee and communicated to Grantee. Upon exercise of the SSARs, the Grantee shall be entitled to
receive the number of shares of Common Stock determined by: 
 (a)        First, calculating the
“spread value” of the SSARs exercised, which is equal to the amount determined by multiplying the number of SSARs exercised times the excess of (i) the Fair Market Value of one share of Common Stock on the exercise date over
(ii) the Exercise Price (set forth in Section 2 above); and then 
 (b)        Dividing the “spread value” by the Fair Market Value of one share of stock on the exercise date to produce the number of whole shares to be received. 
 Upon exercise, the Grantee shall pay or make arrangements acceptable to the Company for the payment of any required withholding taxes in cash. Notwithstanding the
foregoing, the Committee may expressly require withholding, or permit the Grantee to elect to have withholding, of shares of Common Stock deliverable from the exercise having an aggregate Fair Market Value on the exercise date equal to the amount of
the required withholding taxes. The value of any shares so withheld may not be in excess of the amount of taxes required to be withheld by the Company determined by applying the applicable minimum required withholding tax rates. Upon the proper
exercise of the SSARs, and satisfaction of required withholding taxes, the Company shall issue in Grantee’s name and deliver to Grantee (or to Grantee’s permitted representative and in their name upon Grantee’s death, above), in
either book entry or certificate form (in the discretion of the Company) through the Company’s transfer agent, the number of shares acquired through the exercise (net of any shares withheld for such taxes). Grantee shall not have any rights as
a shareholder of the Company with respect to any unexercised portion of the SSARs. 
  

 3 








 5.        Securities Laws. Grantee’s SSARs shall not
be exercised if the exercise would violate: 
 (a)        Any applicable state securities law;

 (b)        Any applicable registration or other requirements under the Securities Act of 1933, as
amended (the “Act”) the Securities Exchange Act of 1934, as amended, or the listing requirements of the NYSE; or 
 (c)        Any applicable legal requirements of any governmental authority. 
 6.        Miscellaneous. 
 (a)        Rights as a Stockholder. Neither Grantee nor Grantee’s representative shall have any rights as a stockholder with respect to any shares underlying the SSARs until the date that
the Company is obligated to deliver such shares of Common Stock to Grantee or Grantee’s representative pursuant to a timely exercise thereof. 
 (b)        No Retention Rights. Nothing in this Agreement shall confer upon Grantee any right to continue in the employment or service of the Company for any period of specific duration or
interfere with or otherwise restrict in any way the rights of the Company or of Grantee, which rights are hereby expressly reserved by each, to terminate his employment or service at any time and for any reason, with or without Cause. 
 (c)        Inconsistency. To the extent any terms and conditions herein conflict with the terms and
conditions of the Plan, the terms and conditions of the Plan shall control. 
 (d)        Notices. Any notice required by the terms of this Agreement shall be given in writing and shall be deemed effective upon personal delivery, upon deposit with the United States Postal
Service, by registered or certified mail, with postage and fees prepaid or upon deposit with a reputable overnight courier. Notice shall be addressed to the Company at its principal executive office and to Grantee at the address that he most
recently provided to the Company. 
 (e)        Entire Agreement; Amendment; Waiver. This
Agreement constitutes the entire contract between the parties hereto with regard to the subject matter hereof. This Agreement supersedes any other agreements, representations or understandings (whether oral or written and whether express or implied)
which relate to the subject matter hereof. No alteration or modification of this Agreement shall be valid except by a subsequent written instrument executed by the parties hereto. No provision of this Agreement may be waived except by a writing
executed and delivered by the party sought to be charged. Any such written waiver will be effective only with respect to the event or circumstance described therein and not with respect to any other event or circumstance, unless such waiver
expressly provides to the contrary. 
 (f)        Choice of Law. This Agreement shall be
governed by, and construed in accordance with, the laws of the State of Illinois, as such laws are applied to contracts entered into and performed in such State, without giving effect to the choice of law provisions thereof. 
  

 4 








 (g)        Successors. 
 (i)        This Agreement is personal to Grantee and shall not be assignable by Grantee otherwise than by will or
the laws of descent and distribution, without the written consent of the Company. This Agreement shall inure to the benefit of and be enforceable by Grantee’s legal representatives. 
 (ii)        This Agreement shall inure to the benefit of and be binding upon the Company and its successors.

 (h)        Severability. If any provision of this Agreement for any reason shall be found by
any court of competent jurisdiction to be invalid, illegal or unenforceable, in whole or in part, such declaration shall not affect the validity, legality or enforceability of any remaining provision or portion thereof, which remaining provision or
portion thereof shall remain in full force and effect as if this Agreement had been adopted with the invalid, illegal or unenforceable provision or portion thereof eliminated. 
 (i)        Headings. The headings, captions and arrangements utilized in this Agreement shall not be
construed to limit or modify the terms or meaning of this Agreement. 
 (j)        Counterparts. This Agreement may be executed simultaneously in one or more counterparts, each of which shall be deemed an original, but all of which shall constitute but one and the
same instrument. 
 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date and year first written above.

  

			
	ACCO BRANDS CORPORATION
		
	By:	 	  

		
	Name:	 	  

		
	Its:	 	  

	
	  

	Grantee Name
	
	  

	Grantee Signature


  

 5